Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
42.96B | 44.62B | 56.90B | 54.97B | 38.54B | Gross Profit |
4.61B | 5.06B | 8.56B | 10.78B | 5.20B | EBIT |
0.00 | 2.96B | 6.87B | 8.88B | 3.85B | EBITDA |
5.30B | 4.00B | 9.50B | 11.68B | 5.54B | Net Income Common Stockholders |
1.20B | 589.00M | 4.58B | 6.31B | 1.23B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.19B | 2.99B | 3.89B | 2.99B | 5.10B | Total Assets |
57.31B | 57.97B | 60.60B | 62.99B | 61.47B | Total Debt |
17.64B | 16.45B | 16.71B | 16.14B | 19.04B | Net Debt |
15.46B | 13.46B | 12.82B | 13.15B | 13.94B | Total Liabilities |
39.46B | 38.86B | 39.36B | 44.25B | 48.47B | Stockholders Equity |
17.85B | 18.61B | 20.72B | 18.16B | 12.44B |
Cash Flow | Free Cash Flow | |||
-151.00M | 2.72B | 5.42B | 4.68B | 4.84B | Operating Cash Flow |
2.91B | 5.20B | 7.47B | 7.01B | 6.23B | Investing Cash Flow |
-2.37B | -2.93B | -2.97B | -2.91B | -841.00M | Financing Cash Flow |
-1.17B | -3.12B | -3.36B | -6.07B | -2.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $10.72B | 12.13 | 16.11% | 3.50% | 1.91% | 2.94% | |
71 Outperform | $89.30B | 33.67 | 69.05% | 0.80% | 0.20% | 14.31% | |
70 Outperform | $32.48B | 46.48 | 3.12% | 1.96% | 2.64% | 80.37% | |
65 Neutral | $24.80B | 18.32 | 19.13% | 2.46% | -4.59% | 11.09% | |
59 Neutral | $23.76B | 17.69 | 10.69% | 7.17% | -1.46% | -36.00% | |
58 Neutral | $25.07B | 22.75 | 6.14% | 7.86% | -3.72% | 91.57% | |
47 Neutral | $2.64B | -4.00 | -31.55% | 3.33% | 2.93% | -29.90% |
On February 25, 2025, The Dow Chemical Company announced a cash tender offer to purchase up to $1 billion of certain debt securities from itself and its subsidiaries, Rohm and Haas Company and Union Carbide Corporation. This move is part of Dow’s strategy to manage its debt portfolio, potentially impacting its financial flexibility and market positioning. The tender offer is subject to a financing condition and will expire on March 25, 2025, with the possibility of early settlement for securities tendered by March 10, 2025.